)
Visual
test
Hypera
Hypera (HYPE3) investor relations material
Hypera Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary29 Oct, 2025
Executive summary
Net revenue reached R$2,227.2 million in 3Q25, up 16.3% year-over-year, driven by strong retail sell-out and working capital optimization.
Retail sell-out grew 8.3% year-over-year, outpacing the market by 1.9 percentage points and improving 2.8 percentage points over 2Q25.
Record operating cash flow reached R$853.6 million, supported by reduced working capital investments.
EBITDA margin from continuing operations rose to 34.0%, reflecting improved operating leverage and product mix.
Interest on Equity of R$185.1 million (R$0.29/share) approved for the quarter.
Financial highlights
Gross margin improved to 61.2%, an increase of 140 basis points year-over-year.
EBITDA from continuing operations rose 34.7% to R$756.2 million, margin at 34.0%.
Net earnings from continuing operations were R$453.9 million, up 22.6% year-over-year.
Free cash flow for 3Q25 was R$854 million.
Net debt after hedge at R$7,268.8 million, or 2.4x annualized EBITDA.
Outlook and guidance
Focus on sustainable growth through innovation, new product launches, and market share expansion in key categories.
Pipeline includes launches in new markets, especially as patents expire (e.g., semaglutide, dapagliflozin).
Confident in approval and launch of semaglutide post-patent expiry, aiming for branded product positioning.
Expect operational cash flow to be lower in Q4 due to dividend and OTCP payments.
Management highlights continued growth prospects, with forward-looking statements dependent on market conditions, regulations, and economic performance.
How did working capital optimization impact 3Q25?
Detail drivers of retail market outperformance.
Explain the debenture issuance and debt reduction strategy.
What is the competitive edge for semaglutide launch?
Describe R&D focus beyond patent expirations
What drives the institutional market shift to private?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 7 FebPGIL
Strong 9MFY26 growth with 13.2% higher revenue, margin gains, and upgraded credit ratings. - 7 Feb504614
Strong revenue and profit growth in Q3 FY26, led by power and steel segments. - 7 FebCHEMPLASTS
Net losses widened and revenue fell year-over-year amid regulatory and market headwinds. - 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026.
Next Hypera earnings date
Q4 202513 Mar, 2026
Hypera
Next Hypera earnings date
Q4 202513 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Hypera S.A. operates as a pharmaceutical company in Brazil. The company is involved in the production, research and development, marketing, sale and distribution of medicinal products for the treatment of various diseases such as diabetes, asthma, epilepsy and other disorders. Hypera S.A. engages through Pharmaceuticals and Biotechnologies segments. The Pharmaceuticals segment promotes and sells hyperbaric oxygen therapy (HOT) chambers to treat burns; Cortical Stimulation Therapy (CST); foot orthoses; jogging rollers; heart valves, pacemakers and implantable cardioverter defibrillator; the pregnancy test kit, pregnancy urine test kit and ovulation predictors; and iron supplements.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage